• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在转录相互作用分析中,睾酮抑制过氧化物酶体增殖物激活受体γ的活性。

Testosterone inhibits the activity of peroxisome proliferator-activated receptor gamma in a transcriptional transaction assay.

作者信息

Du J, Zhang L, Wang Z

机构信息

Protein Science Key Laboratory of the Ministry of Education, Department of Biological Sciences and Biotechnology, School of Medicine, Tsinghua University, Beijing, PR China.

出版信息

Pharmazie. 2009 Oct;64(10):692-3.

PMID:19947175
Abstract

Emerging evidences suggest that testosterone is an important regulator of body fat mass in men. However, the mechanism underlying the regulation of body composition by testosterone is not well understood. The paper demonstrates testosterone inhibited the activity of peroxisome proliferator-activated receptor gamma (PPARgamma), which controls the adipogenic differentiation and lipid metabolism. Pre-inhibition of androgen receptor did not influence the inhibition of PPARgamma activity by testosterone. Moreover, pre-treatment with testosterone attenuated the insulin-induced up-regulation of PPARgamma activity. These results provide a novel mechanism for the effect of testosterone on fat mass control.

摘要

新出现的证据表明,睾酮是男性体内脂肪量的重要调节因子。然而,睾酮调节身体成分的潜在机制尚未完全明确。该论文表明,睾酮抑制了过氧化物酶体增殖物激活受体γ(PPARγ)的活性,而PPARγ控制着脂肪生成分化和脂质代谢。预先抑制雄激素受体并不影响睾酮对PPARγ活性的抑制作用。此外,睾酮预处理减弱了胰岛素诱导的PPARγ活性上调。这些结果为睾酮对脂肪量控制的作用提供了一种新机制。

相似文献

1
Testosterone inhibits the activity of peroxisome proliferator-activated receptor gamma in a transcriptional transaction assay.在转录相互作用分析中,睾酮抑制过氧化物酶体增殖物激活受体γ的活性。
Pharmazie. 2009 Oct;64(10):692-3.
2
Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.小檗碱通过抑制过氧化物酶体增殖物激活受体γ和脂肪酸转移酶的表达改善游离脂肪酸诱导的L6肌管胰岛素抵抗。
Metabolism. 2009 Dec;58(12):1694-702. doi: 10.1016/j.metabol.2009.06.009. Epub 2009 Sep 19.
3
Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.过氧化物酶体增殖物激活受体γ通过以Sp1依赖的方式上调p21Cip1/WAF1基因来抑制滤泡性和间变性甲状腺癌细胞的生长。
Endocr Relat Cancer. 2008 Jun;15(2):545-57. doi: 10.1677/ERC-07-0272.
4
Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.体重减轻相关的过氧化物酶体增殖物激活受体α和过氧化物酶体增殖物激活受体γ的诱导与肥胖胰岛素抵抗小鼠动脉粥样硬化减轻及心血管功能改善相关。
Circulation. 2004 Nov 16;110(20):3259-69. doi: 10.1161/01.CIR.0000147614.85888.7A. Epub 2004 Nov 8.
5
Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.噻唑烷二酮类/过氧化物酶体增殖物激活受体γ通过抑制c-Jun氨基末端激酶途径发挥降血糖作用。
Diabetes. 2007 Jul;56(7):1865-71. doi: 10.2337/db06-1293. Epub 2007 Apr 6.
6
Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.过氧化物酶体增殖物激活受体γ拮抗剂对许多造血和上皮癌细胞系表现出强大的抗增殖作用。
Anticancer Drugs. 2007 Jun;18(5):525-34. doi: 10.1097/CAD.0b013e3280200414.
7
A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.一种过氧化物酶体增殖物激活受体γ拮抗剂可诱导波形蛋白裂解并抑制高级别肝细胞癌的侵袭。
Oncol Rep. 2007 Oct;18(4):825-32.
8
A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.一种具有独特脂肪细胞调节特性的选择性过氧化物酶体增殖物激活受体γ调节剂。
J Pharmacol Exp Ther. 2006 Aug;318(2):863-71. doi: 10.1124/jpet.106.102459. Epub 2006 May 8.
9
Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.过氧化物酶体增殖物激活受体γ调节信号转导和转录激活因子5A的表达。
Exp Cell Res. 2006 May 1;312(8):1371-80. doi: 10.1016/j.yexcr.2005.12.023. Epub 2006 Feb 2.
10
Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?过氧化物酶体增殖物激活受体γ:癌症治疗的新靶点?
Anticancer Drugs. 2007 Mar;18(3):237-44. doi: 10.1097/CAD.0b013e328011e67d.

引用本文的文献

1
Influences of Sex and Estrogen in Arterial and Valvular Calcification.性别与雌激素对动脉和瓣膜钙化的影响。
Front Endocrinol (Lausanne). 2019 Sep 20;10:622. doi: 10.3389/fendo.2019.00622. eCollection 2019.
2
In Vivo RNAi Screen Unveils PPARγ as a Regulator of Hematopoietic Stem Cell Homeostasis.体内 RNAi 筛选揭示 PPARγ 是造血干细胞稳态的调节因子。
Stem Cell Reports. 2017 May 9;8(5):1242-1255. doi: 10.1016/j.stemcr.2017.03.008. Epub 2017 Apr 13.
3
Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?
主动脉瓣狭窄的病理生理学:它既是纤维钙化性的又是性别特异性的吗?
Physiology (Bethesda). 2017 May;32(3):182-196. doi: 10.1152/physiol.00025.2016.
4
Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation.体内的身体成分变化和脂肪发育抑制表明雄激素参与调节干细胞谱系分配。
J Cell Biochem. 2011 Jul;112(7):1773-86. doi: 10.1002/jcb.23098.
5
Genistein and daidzein repress adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via Wnt/β-catenin signalling or lipolysis.金雀异黄素和大豆苷元通过 Wnt/β-连环蛋白信号通路或脂肪分解抑制人脂肪组织来源间充质干细胞的成脂分化。
Cell Prolif. 2010 Dec;43(6):594-605. doi: 10.1111/j.1365-2184.2010.00709.x.